
doi: 10.1002/hep.24660
pmid: 21898509
Liver Cirrhosis, Male, Evidence-Based Medicine, Dose-Response Relationship, Drug, Biopsy, Needle, Hepatitis C, Chronic, Middle Aged, Immunohistochemistry, Risk Assessment, Severity of Illness Index, Drug Administration Schedule, Treatment Outcome, Humans, Protease Inhibitors, Oligopeptides, Follow-Up Studies
Liver Cirrhosis, Male, Evidence-Based Medicine, Dose-Response Relationship, Drug, Biopsy, Needle, Hepatitis C, Chronic, Middle Aged, Immunohistochemistry, Risk Assessment, Severity of Illness Index, Drug Administration Schedule, Treatment Outcome, Humans, Protease Inhibitors, Oligopeptides, Follow-Up Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
